Unichem Labs net loss narrows to Rs 22 crore in September quarter
Unichem Labs had posted a net loss of Rs 41.03 crore for the corresponding period of the previous fiscal, the company said in a filing to the BSE.
New Delhi: Drug firm Unichem Laboratories on Saturday reported a narrowing of its consolidated net loss to Rs 22.20 crore for the quarter ended September 30, 2019.
The company had posted a net loss of Rs 41.03 crore for the corresponding period of the previous fiscal, Unichem Laboratories said in a filing to the BSE.
Also Read: Unichem Labs standalone net profit declines 99.83 per cent in Q3
Its consolidated revenue from operations stood at Rs 295.60 crore for the quarter under consideration. It was Rs 261.15 crore for the same period a year ago, it added.
Unichem Labs manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world. The Company has skills in product development, process chemistry and manufacturing complex API as well as dosage forms.
Also Read: Unichem Laboratories Q4 net profit up 13% at Rs 31.46 cr
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd